. 2021 Aug 2;36(1):1760–1782. doi: 10.1080/14756366.2021.1956488

Table 3.

Stages of the cell death process in HepG2 cells after treatment with compound 27a.

Sample	Viable^a (left bottom)	Apoptosis^a		Necrosis^a (left top)
Sample	Viable^a (left bottom)	Early (right bottom)	Late (right top)	Necrosis^a (left top)
HepG2	91.20 ± 1.16	8.52 ± 1.16	0.14 ± 0.01	0.14 ± 0.011
Compound 27a/HepG2	58.98 ± 2.64	40.47 ± 2.55***	0.35 ± 0.06	0.20 ± 0.04

^aValues are given as mean ± SEM of three independent experiments.

***p < 0.001 indicates statistically significant difference from the corresponding control (HepG2) group in unpaired t-test.